Zobrazeno 1 - 7
of 7
pro vyhledávání: '"McManigle WC"'
Autor:
Bracken SJ; Division of Rheumatology and Immunology, Department of Medicine, Duke University Medical Center, Durham, NC., Suthers AN; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC., DiCioccio RA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC., Su H; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC., Anand S; Division of Hematology and Medical Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI., Poe JC; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC., Jia W; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC., Visentin J; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC.; Department of Immunology and Immunogenetics, Bordeaux University Hospital, Bordeaux, France.; UMR CNRS 5164 ImmunoConcEpT, Bordeaux University, Bordeaux, France., Basher F; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC., Jordan CZ; Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham NC., McManigle WC; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham NC., Li Z; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham NC.; Duke Cancer Institute, Duke University Medical Center, Durham NC., Hakim FT; Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD., Pavletic SZ; Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD., Bhuiya NS; Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD., Ho VT; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC.; Duke Cancer Institute, Duke University Medical Center, Durham NC., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC.; Duke Cancer Institute, Duke University Medical Center, Durham NC.; Department of Integrated Immunobiology, Duke University School of Medicine, Durham, NC., Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC.; Duke Cancer Institute, Duke University Medical Center, Durham NC.; Department of Integrated Immunobiology, Duke University School of Medicine, Durham, NC.
Publikováno v:
Blood advances [Blood Adv] 2024 Feb 13; Vol. 8 (3), pp. 667-680.
Autor:
Poe JC; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Fang J; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA., Zhang D; Duke Cancer Institute, Durham, North Carolina, USA., Lee MR; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA., DiCioccio RA; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Su H; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Qin X; Duke Cancer Institute, Durham, North Carolina, USA., Zhang JY; Department of Dermatology, Duke University Medical Center, Durham, North Carolina, USA., Visentin J; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Department of Immunology and Immunogenetics, Bordeaux University Hospital, Bordeaux, France.; UMR CNRS 5164 ImmunoConcEpT, Bordeaux University, Bordeaux, France., Bracken SJ; Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, North Carolina, USA., Ho VT; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wang KS; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rose JJ; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Pavletic SZ; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Hakim FT; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Jia W; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Suthers AN; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Curry-Chisolm IM; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Horwitz ME; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Duke Cancer Institute, Durham, North Carolina, USA., Rizzieri DA; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Duke Cancer Institute, Durham, North Carolina, USA., McManigle WC; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Chao NJ; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Duke Cancer Institute, Durham, North Carolina, USA.; Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA., Cardones AR; Department of Dermatology, Duke University Medical Center, Durham, North Carolina, USA., Xie J; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute, Durham, North Carolina, USA., Owzar K; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute, Durham, North Carolina, USA., Sarantopoulos S; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Duke Cancer Institute, Durham, North Carolina, USA.; Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Publikováno v:
JCI insight [JCI Insight] 2023 Jun 08; Vol. 8 (11). Date of Electronic Publication: 2023 Jun 08.
Autor:
Petkovich BW; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., McManigle WC; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Chopra A; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Albany Medical College, Albany, NY, USA., Huggins JT; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Publikováno v:
Respiratory medicine case reports [Respir Med Case Rep] 2023 Mar 08; Vol. 43, pp. 101832. Date of Electronic Publication: 2023 Mar 08 (Print Publication: 2023).
Autor:
Lin C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., DiCioccio RA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Haykal T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., McManigle WC; Division of Pulmonary and Critical Care, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina., Li Z; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina., Anand SM; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, Michigan., Poe JC; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Bracken SJ; Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Jia W; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Alyea EP 3rd; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Cardones AR; Division of Dermatology, Department of Internal Medicine, University of Kansas Medical Center, Lawrence, Kansas., Choi T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Hennig T; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Kang Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Lopez R; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Martin M; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Minor KK; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Quinones VLP; Duke Eye Center, Durham, North Carolina., Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Wiggins K; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Rizzieri DA; Novant Health Cancer Institute, Charlotte, North Carolina., Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina. Electronic address: stefanie.sarantopoulos@duke.edu.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Mar; Vol. 29 (3), pp. 179.e1-179.e10. Date of Electronic Publication: 2022 Dec 25.
Autor:
Mosher CL; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University, Durham, North Carolina., Smith JB; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University, Durham, North Carolina., McManigle WC; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University, Durham, North Carolina., Giovacchini CX; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University, Durham, North Carolina., Shofer SL; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University, Durham, North Carolina.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Aug 15; Vol. 202 (4), pp. 595-597.
Autor:
Barbour AB; School of Medicine, Duke University, Durham, NC, USA., Frush JM; School of Medicine, Duke University, Durham, NC, USA., Gatta LA; School of Medicine, Duke University, Durham, NC, USA., McManigle WC; School of Medicine, Duke University, Durham, NC, USA., Keah NM; Wake Forest School of Medicine, Wake Forest University, Winston-Salem, NC, USA., Bejarano-Pineda L; School of Medicine, Duke University, Durham, NC, USA., Guerrero EM; School of Medicine, Duke University, Durham, NC, USA.
Publikováno v:
Journal of medical education and curricular development [J Med Educ Curric Dev] 2020 Jan 28; Vol. 6, pp. 2382120519889348. Date of Electronic Publication: 2020 Jan 28 (Print Publication: 2019).
Autor:
Martinu T; Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.; Department of Internal Medicine, Duke University, Durham, NC., McManigle WC; Department of Internal Medicine, Duke University, Durham, NC., Kelly FL; Department of Internal Medicine, Duke University, Durham, NC., Nelson ME; Department of Internal Medicine, Duke University, Durham, NC., Sun J; Department of Internal Medicine, Duke University, Durham, NC., Zhang HL; Department of Internal Medicine, Duke University, Durham, NC., Kolls JK; Department of Internal Medicine, Center for Translational Research in Infection and Inflammation, Tulane School of Medicine, New Orleans, LA., Gowdy KM; Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC., Palmer SM; Department of Internal Medicine, Duke University, Durham, NC.
Publikováno v:
Transplantation [Transplantation] 2019 Nov; Vol. 103 (11), pp. 2264-2274.